BIOMAT Database Logo BIOMAT Database Logo

[Estrogen excretion in men with various forms of hypogonadism in the late periods after the use of hormone therapy]. 1980

A N Demchenko, and A I Laskavaia, and A I Palienko

UI MeSH Term Description Entries
D007006 Hypogonadism Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism). Hypergonadotropic Hypogonadism,Hypogonadism, Isolated Hypogonadotropic,Hypogonadotropic Hypogonadism,Hypogonadism, Hypergonadotropic,Hypogonadism, Hypogonadotropic
D008297 Male Males
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012741 Sexual Maturation Achievement of full sexual capacity in animals and in humans. Sex Maturation,Maturation, Sex,Maturation, Sexual
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A N Demchenko, and A I Laskavaia, and A I Palienko
[Excretion of testosterone in men with various forms of hypogonadism].
January 1975, Problemy endokrinologii,
A N Demchenko, and A I Laskavaia, and A I Palienko
Various forms of hypogonadism.
October 1946, Bulletin. New England Medical Center Hospital,
A N Demchenko, and A I Laskavaia, and A I Palienko
[Pathomorphological studies of the testes in various forms of hypogonadism in young men].
January 1979, Vutreshni bolesti,
A N Demchenko, and A I Laskavaia, and A I Palienko
[Excretion of various forms of the estrogenic hormone in females].
January 1946, Biulleten' eksperimental'noi biologii i meditsiny,
A N Demchenko, and A I Laskavaia, and A I Palienko
[Gonadotropic hormone excretion in men with hypogonadism and its dynamics under the influence of exogenous testosterone].
January 1975, Problemy endokrinologii,
A N Demchenko, and A I Laskavaia, and A I Palienko
Testosterone therapy in older men with late-onset hypogonadism: a counter-rationale.
January 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
A N Demchenko, and A I Laskavaia, and A I Palienko
The use of estrogen therapy in men.
December 2003, Current opinion in pharmacology,
A N Demchenko, and A I Laskavaia, and A I Palienko
[Serum growth hormone concentration in men with hypogonadism].
January 1971, Problemy endokrinologii,
A N Demchenko, and A I Laskavaia, and A I Palienko
Symptoms of Late-Onset Hypogonadism in Men.
December 2022, Endocrinology and metabolism clinics of North America,
A N Demchenko, and A I Laskavaia, and A I Palienko
Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism.
September 2019, American journal of epidemiology,
Copied contents to your clipboard!